Strikingly, PM01183 efficiently reduced PAX7 and myogenin levels (Figure 4G,K,L), but it is unlikely that such drug completely resolves the myogenic impairment typical of cachexia, as suggested by the failure of PM to restore C/EBPβ to normal levels (Figure 4G,J). This evidence concerns the gene PAX7 and Cachexia.